학술논문
A phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of catch-up vaccination regimens of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants, children, and adolescents (PNEU-PLAN)
Document Type
Article
Author
Source
In: Vaccine . (Vaccine, 19 October 2022, 40(44):6315-6325)
Subject
Language
English
ISSN
18732518
0264410X
0264410X